Boston, MA -- (SBWIRE) -- 01/24/2014 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Merrimack Pharmaceuticals Inc(NASDAQ:MACK), Diana Shipping Inc.(NYSE:DSX), Altisource Residential Corp(NYSE:RESI), BioCryst Pharmaceuticals, Inc.(NASDAQ:BCRX).
Merrimack Pharmaceuticals Inc(NASDAQ:MACK), opened its shares at the price of $6.12 for the day. Its closing price was $6.23 after gaining/ 0.97% for the day. The company traded with the total volume of 1.60 million shares, while its average trading volume remained 2.09 million shares. Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer in the United States.
Will MACK Continue To Move Higher? Find Out Here
Diana Shipping Inc.(NYSE:DSX), percentage change plunged -2.26% to close at $12.55 with the total traded volume of 1.59 million shares, and average volume of 1.44M. The 52 week range of the stock remained $8.24 - $13.93. Diana Shipping Inc. provides shipping transportation services. The company transports dry bulk cargoes, including commodities, such as iron ore, coal, grain, and other materials worldwide.
-Will DSX Get Buyers Even After The Recent Rally? Find Out Here
Altisource Residential Corp(NYSE:RESI), started its trading session with the price of $33.00and closed at $32.40 by scoring -1.85%. RESI’s stocks traded with total volume of 1.58 million shares, while the average trading volume remained 1.19 million shares. Altisource Residential Corporation, through its wholly-owned subsidiary, Altisource Residential L.P., focuses on acquiring, owning, and managing single-family rental properties throughout the United States.
-Will RESI Get Buyers Even After The Recent Rally? Find Out Here
BioCryst Pharmaceuticals, Inc.(NASDAQ:BCRX) ended its day with the gain of 0.25% and closed at the price of $12.17 after opening at $12.20. Stock traded during its last trading session with the total volume of 1.58 million shares, as compared to its average volume of 1.30 million shares. BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops novel drugs that block key enzymes involved in the pathogenesis of diseases.
Will BCRX Continue To Move Higher? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)